FDA Recall Database: Class I Recall: BMC/REACTHEALTH Luna G3 APAP REF LG 3600 by BMC Medical Co., Ltd.

Key facts

What this classification means

A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field. FDA's Center for Devices and Radiological Health (for devices) or Center for Drug Evaluation and Research (for drugs) reviews the classification and can require additional corrective action if the initial response is judged insufficient. Because this record is filed as Class I, professionals and consumers handling an affected lot should treat FDA's own classification -- not this page's summary of it -- as the authoritative risk signal. A Class I recall is FDA’s most serious classification. FDA assigns Class I when there is a reasonable probability that use of, or exposure to, the recalled product will cause serious adverse health consequences or death. This classification does not mean harm has already occurred in every case -- it reflects FDA’s assessment of the realistic worst-case risk profile of the defect described in the recall, based on the reason for recall reported by the firm. Class I recalls receive the closest FDA monitoring of the three classes: the recalling firm typically must submit a recall strategy, periodic status reports, and effectiveness checks confirming that the affected lots have actually been removed from distribution or corrected in the field.

What consumers should do

Facilities, clinicians, and consumers holding an affected unit or lot of BMC/REACTHEALTH Luna G3 APAP REF LG 3600 should stop using it for the purpose described in the recall notice and hold remaining stock pending instructions from BMC Medical Co., Ltd.. FDA recall records typically direct the recalling firm to notify known accounts directly with a recall letter describing the specific corrective action -- replacement, field correction, refund, or return. Anyone who received the product through a distributor rather than directly from BMC Medical Co., Ltd. should confirm with their supplier whether their specific lot or unit is on the affected list, since recall notices are lot- or unit-specific and not every unit of a product line is necessarily included. Questions about a specific unit's status should go to BMC Medical Co., Ltd. directly or to the distributor that supplied it; Argus HQ is a public-record aggregator, not the recalling firm, and cannot confirm individual unit status.

BMC Medical Co., Ltd.’s FDA history

Argus HQ has recorded 2 total FDA actions tied to BMC Medical Co., Ltd.: 1 warning letter, 1 recall, 0 approval records, and 0 Form 483 inspection citations.

Frequently asked questions

Has BMC Medical Co., Ltd. had other FDA recalls or enforcement actions?

Yes. Argus HQ has recorded 2 total FDA actions tied to BMC Medical Co., Ltd., including 1 recall and 1 warning letter.

What is the FDA recall number for this event?

FDA recall number Z-2979-2026.

What is the current status of this recall?

Status as recorded by FDA: Ongoing.

Where can I verify this recall directly with FDA?

The verbatim FDA record is the source of truth for every recall Argus HQ tracks — always confirm against fda.gov before acting.

Related enforcement actions

• Warning letter: BMC Medical Co., Ltd. — CGMP/QSR/Medical Devices/PMA/Adulterated/Misbranded (2026-05-20) →